CTMX

2.0300.98%
MP

Matthew P. Young

Lead Independent Director

Mr. Matthew P. Young, also known as Matt, serves as Managing Director at Longitude Capital Management Co., LLC. His Focus Areas is Biotechnology. He joined Longitude Capital in 2022. He serves as Director at OrsoBio, Inc since November 2023. He serves as Director at Avenge Bio, Inc. since 2022. He served as Chief Operating Officer and Chief Financial Officer at GRAIL, Inc. since October 28, 2019. He serves in the Board of Directors of Alpha9 Theranostics Inc. Mr. Young served as Chief Financial Officer of Jazz Pharmaceuticals Public Limited Company from April 2013 to October 25, 2019 and served as Executive Vice President from February 2015 to October 25, 2019. Mr. Young served as Senior Vice President and Chief Financial Officer at Jazz Pharmaceuticals Public Limited Company from March 2014 to February 2015. Mr. Young served as Senior Vice President of Corporate Development at Jazz Pharmaceuticals Public Limited Company from April 2013 to March 2014. He joined Jazz Pharmaceuticals in early 2013. Mr. Young served as the Managing Director and Head of U S Life Sciences of Corporate & Investment Banking at Citigroup Global Markets Inc., from May 24, 2007 until 2008. From 1992 to 2003, Mr. Young served in various capacities at other investment banking firms. His most recent investment banking role was as the Managing Director in Global Healthcare and Co-Head of Life Sciences at Barclays Capital from February 2009 to April 2013. He served as the Head of West Coast Healthcare and directed the life sciences coverage effort at Lehman Brothers Inc. from 2003 to 2007. He serves as Director of Alpha-9 Theranostics, Inc. He served as an Independent Director of PRA Health Sciences, Inc. since February 2015 until July 1, 2021. He has been a Lead Independent Director of CytomX Therapeutics, Inc. since December 31, 2018 and has been its Director since September 2015. He has worked on numerous mergers and acquisitions, corporate finance, and other transactions during his career. He is director of AllinBio. Mr. Young received his B.S. in Economics and his M.B.A. from the Wharton School of Business of the University of Pennsylvania.

Positions